Patents by Inventor Frances Margaret Price

Frances Margaret Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumour Markers
    Publication number: 20120115749
    Abstract: A method of determining the immune response of a mammal to circulating tumour marker proteins is described in which a sample of bodily fluid, for example plasma or serum, is contacted with a panel of two or more distinct tumour marker antigen. The presence of complexes between the tumour marker antigens and any autoantibodies to the antigens present in the sample are detected and provide an indication of an immune response to a circulating tumour marker protein. The method is useful for the diagnosis of cancer, particularly for identifying new or recurrent cancer in an otherwise assymptomatic patient.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 10, 2012
    Applicant: Onclmmune Limited
    Inventors: John F.R. Robertson, Catherine R.L. Graves, Michael R. Price, Frances Margaret Price
  • Tumour markers
    Patent number: 8114604
    Abstract: A method of determining the immune response of a mammal to circulating tumour marker proteins is described in which a sample of bodily fluid, for example plasma or serum, is contacted with a panel of two or more distinct tumour marker antigen. The presence of complexes between the tumour marker antigens and any autoantibodies to the antigens present in the sample are detected and provide an indication of an immune response to a circulating tumour marker protein. The method is useful for the diagnosis of cancer, particularly for identifying new or recurrent cancer in an otherwise assymptomatic patient.
    Type: Grant
    Filed: December 10, 2007
    Date of Patent: February 14, 2012
    Assignee: OncImmune Ltd.
    Inventors: John F. R. Robertson, Catherine R. L. Graves, Michael R. Price, Frances Margaret Price, legal representative
  • Cancer Detection Methods and Reagents
    Publication number: 20110086061
    Abstract: The present invention comprises methods and compositions for detecting cancer in an individual comprising autoantibodies to cancer-associated antigens. Specifically, the present invention comprises methods and compositions for detecting autoantibodies to cancer-associated antigen in a bodily fluid as well as use of said autoantibodies as a means to detect the presence of cancer-associated antigens.
    Type: Application
    Filed: December 14, 2010
    Publication date: April 14, 2011
    Applicant: Onclmmune Limited
    Inventors: John Forsyth Russell Robertson, Catherine Rosamund Louise Graves, Michael Rawling Price, Frances Margaret Price
  • Cancer Detection Methods and Reagents
    Publication number: 20080108084
    Abstract: Sensitive and specific methods are provided for use in detecting the presence of cancer marker proteins in the body fluids of a mammal. Also provided are autoantibodies for use in these methods, and immortalized cells which are a source of the autoantibodies.
    Type: Application
    Filed: March 5, 2007
    Publication date: May 8, 2008
    Applicant: UNIVERSITY OF NOTTINGHAM
    Inventors: John Russell Robertson, Catherine Rosamund Louise Graves, Michael Rawling Price, Frances Margaret Price
  • Cancer detection method and reagents
    Patent number: 7205117
    Abstract: Sensitive and specific methods are provided for use in detecting the presence of cancer marker proteins in the body fluids of a mammal. Also provided are autoantibodies for use in these methods and immortalized cells, which are a source of the autoantibodies.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: April 17, 2007
    Assignee: University of Nottingham
    Inventors: John Forsyth Russell Robertson, Catherine Rosemund Graves, Michael Rawling Price, Frances Margaret Price
  • Cancer detection methods and reagents
    Publication number: 20030232399
    Abstract: The present invention comprises methods and compositions for detecting cancer in an individual comprising autoantibodies to cancer-associated antigens. Specifically, the present invention comprises methods and compositions for detecting autoantibodies to cancer-associated antigen in a bodily fluid as well as use of said autoantibodies as a means to detect the presence of cancer-associated antigens.
    Type: Application
    Filed: April 16, 2003
    Publication date: December 18, 2003
    Inventors: John Forsyth Russell Robertson, Catherine Rosamund Louise Graves, Michael Rawling Price, Frances Margaret Price